1. Home
  2. KMDA vs PKST Comparison

KMDA vs PKST Comparison

Compare KMDA & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • PKST
  • Stock Information
  • Founded
  • KMDA 1990
  • PKST 2008
  • Country
  • KMDA Israel
  • PKST United States
  • Employees
  • KMDA N/A
  • PKST N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • KMDA Health Care
  • PKST Real Estate
  • Exchange
  • KMDA Nasdaq
  • PKST Nasdaq
  • Market Cap
  • KMDA 430.1M
  • PKST 454.7M
  • IPO Year
  • KMDA N/A
  • PKST N/A
  • Fundamental
  • Price
  • KMDA $7.35
  • PKST $12.26
  • Analyst Decision
  • KMDA Strong Buy
  • PKST Buy
  • Analyst Count
  • KMDA 2
  • PKST 2
  • Target Price
  • KMDA $13.00
  • PKST $16.00
  • AVG Volume (30 Days)
  • KMDA 49.4K
  • PKST 184.2K
  • Earning Date
  • KMDA 08-13-2025
  • PKST 08-07-2025
  • Dividend Yield
  • KMDA 2.72%
  • PKST 7.39%
  • EPS Growth
  • KMDA 27.97
  • PKST N/A
  • EPS
  • KMDA 0.32
  • PKST N/A
  • Revenue
  • KMDA $169,517,000.00
  • PKST $223,891,000.00
  • Revenue This Year
  • KMDA $14.51
  • PKST N/A
  • Revenue Next Year
  • KMDA $9.31
  • PKST N/A
  • P/E Ratio
  • KMDA $22.26
  • PKST N/A
  • Revenue Growth
  • KMDA 9.67
  • PKST N/A
  • 52 Week Low
  • KMDA $5.17
  • PKST $10.14
  • 52 Week High
  • KMDA $9.16
  • PKST $16.26
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 48.99
  • PKST 36.58
  • Support Level
  • KMDA $7.15
  • PKST $11.56
  • Resistance Level
  • KMDA $7.85
  • PKST $12.60
  • Average True Range (ATR)
  • KMDA 0.22
  • PKST 0.49
  • MACD
  • KMDA 0.00
  • PKST -0.19
  • Stochastic Oscillator
  • KMDA 54.13
  • PKST 28.65

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: